BUYO - ETF AI Analysis

Top Page

KraneShares Man Buyout Beta Index ETF (BUYO)

Rating:67Neutral

Price Target:―

BUYO’s rating suggests it is a reasonably solid ETF, supported by strong holdings like Onto Innovation and ATI, which benefit from robust financial health, positive earnings sentiment, and bullish technical trends, especially in growth areas such as aerospace and defense. However, weaker names like Amneal Pharmaceuticals and Lifestance Health Group, which face profitability and valuation challenges, modestly weigh on the fund’s overall quality. The main risk factor is exposure to several stocks with high valuations, which could make the ETF more sensitive if market sentiment toward richly priced companies turns negative.

Positive Factors

Strong Recent Performance

The ETF has delivered strong gains so far this year and over the past three months, indicating solid recent momentum.

Broad Sector Diversification

Holdings are spread across many sectors, including technology, industrials, consumer, health care, and financials, which helps reduce reliance on any single part of the market.

Strong Top Holdings Performance

Many of the top positions, such as Flex, Jabil, Materion, and DigitalOcean, have shown strong year-to-date performance, supporting the fund’s overall returns.

Negative Factors

High Expense Ratio

The fund’s expense ratio is relatively high for an ETF, which means more of the returns are used to cover fees.

Heavy U.S. Concentration

Almost all of the ETF’s assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.

Small Asset Base

The ETF manages a relatively small amount of assets, which can sometimes lead to higher trading costs and a greater risk that the fund could be closed in the future.

BUYO vs. SPDR S&P 500 ETF (SPY)

AUM17.86M

RegionNorth America

Expense Ratio0.89%

Beta1.07

IssuerKraneShares

Inception DateOct 08, 2024

Dividend Yield0.01%

Asset ClassEquity

Index TrackedMan Buyout Beta Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume1,360

30 Day Avg. Volume874

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

40.73

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering321

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

BUYO Summary

KraneShares Man Buyout Beta Index ETF (BUYO) is an exchange-traded fund that follows the Man Buyout Beta Index, focusing on smaller U.S. companies that may be attractive buyout targets. It spreads investments across many sectors, including technology, industrials, health care, and consumer companies. Well-known names in the fund include News Corp and Teladoc. An investor might choose BUYO to seek growth and diversification beyond the largest, most familiar stocks, especially in companies that could benefit from mergers or acquisitions. A key risk is that these smaller stocks can be more volatile and can go up and down sharply with the market.

How much will it cost me?The KraneShares Man Buyout Beta Index ETF (BUYO) has an expense ratio of 0.89%, meaning you’ll pay $8.90 per year for every $1,000 invested. This is higher than average because BUYO is actively managed, focusing on specialized smaller companies with buyout potential, which requires more research and management effort.

What would affect this ETF?The BUYO ETF's focus on smaller U.S. companies with buyout potential could benefit from economic growth, innovation in the technology and industrial sectors, and increased merger and acquisition activity. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns that could negatively impact consumer cyclical and industrial sectors. Its heavy exposure to technology also makes it sensitive to regulatory changes or shifts in market sentiment toward high-growth industries.

BUYO Top 10 Holdings

BUYO leans into U.S. mid- and small-cap names, with a noticeable tilt toward tech, health care, and industrials. High-flyers like Materion and Onto Innovation have been powering the fund, riding strong momentum in specialized materials and semiconductor equipment. Amneal Pharmaceuticals is also rising, giving the health care sleeve a helpful boost. On the flip side, Teladoc is clearly dragging the fund, and Asana has been mixed, losing steam despite earlier strength. Overall, performance is being driven by a handful of niche growth stories rather than broad market giants.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
NWSA	News Corp	1.66%	$290.91K	$16.04B	1.09%	67 Neutral
EHC	Encompass Health	1.38%	$241.64K	$11.82B	-2.78%	64 Neutral
MTRN	Materion	1.27%	$222.95K	$6.50B	150.89%	69 Neutral
AMG	Affiliated Managers	1.11%	$194.14K	$9.61B	52.83%	74 Outperform
ONTO	Onto Innovation	1.10%	$192.70K	$16.09B	128.08%	82 Outperform
ATI	ATI	0.98%	$171.22K	$26.20B	136.74%	78 Outperform
AMRX	Amneal Pharmaceuticals	0.97%	$169.34K	$6.48B	95.38%	58 Neutral
LFST	Lifestance Health Group	0.94%	$164.70K	$4.52B	114.70%	61 Neutral
ASAN	Asana	0.94%	$163.96K	$1.97B	-36.85%	57 Neutral
MTCH	Match Group	0.92%	$160.80K	$9.26B	17.48%	66 Neutral

BUYO Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

33.05

Negative

100DMA

32.59

Positive

200DMA

30.76

Positive

Market Momentum

MACD

-0.20

Negative

RSI

54.70

Neutral

STOCH

69.55

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BUYO, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 32.35, equal to the 50-day MA of 33.05, and equal to the 200-day MA of 30.76, indicating a neutral trend. The MACD of -0.20 indicates Negative momentum. The RSI at 54.70 is Neutral, neither overbought nor oversold. The STOCH value of 69.55 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BUYO.

BUYO Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
BUYO	―	―	$17.86M	0.89%	67 Neutral
OASC	―	―	$95.84M	0.69%	68 Neutral
FSCS	―	―	$56.76M	0.60%	74 Outperform
MYLD	―	―	$50.78M	0.62%	67 Neutral
TMFX	―	―	$36.18M	0.50%	69 Neutral
BCSM	―	―	$35.65M	0.75%	58 Neutral

Performance Comparison

BUYO

KraneShares Man Buyout Beta Index ETF

32.83

6.04

22.55%

OASC

OneAscent Small Cap Core ETF

―

FSCS

First Trust Smid Capital Strength Etf

―

MYLD

Cambria Micro and SmallCap Shareholder Yield ETF

―

TMFX

Motley Fool Next Index ETF

―

BCSM

Baron SMID Cap ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents